|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The execution of the transcriptional axismutant p53, E2F1 and ID4 promotes tumor neo -angiogenesis显示文摘 | Fontemaggi G Dell Orso S Trisciuoglio D | 2009 | Nat Struet Mol Biol2009，6，10： | 1 |
| 2 | Functional activity of CXCL8 receptors,CXCR1 and CXCR2,on human malignant Melanoma progression显示文摘 | Gabellini C Trisciuoglio D Desideri M | 2009 | Eur J Cancer2009，45，14： | 1 |
| 3 | Functional activityof CXCL8 receptors, CXCR1 and CXCR2, on human malignantmelanoma progression 显示文摘 | Gabellini C Trisciuoglio D Desideri M | 2009 | Eur J Cancer2009，45，14： | 1 |
| 4 | Bcl-2 overexpression in human melanoma ceils increases angiogenesis through VEGF mRNA stabilization and HIF-1-mediated transcriptional activity显示文摘 | Iervolino A Trisciuoglio D Ribatti D | 2002 | FASEB J2002，16，11： | 1 |
| 5 | Bcl-2 has differing effects on the sensitivity of breast cancer cells depending on the antineoplastic drug used显示文摘 | Del Bufalo D Biroccio A Trisciuoglio D | 2002 | Eur J Cancer2002，38，18： | 1 |
| 6 | Bcl-2 has differing effects on the sensitivity of breast cancer cells depending on the antineoplastic drug used 显示文摘 | Del Bufalo D Biroccio A Trisciuoglio D | 2002 | Eur J Cancer2002，38，18： | 1 |
| 7 | Differential involvement of vascular endothelial growth factor in the survival of hypoxic colon cancer cells显示文摘 | CALVANI M TRISCIUOGLIO D BERGAMASCHI C | 2008 | Cancer Res2008，68，1： | 1 |
| 8 | Bcl-2 has differing effects on the sensitivity of breast cancer cells depending on the antineoplastic drug used显示文摘 | Biroccio A Trisciuoglio D | 2002 | Eur J Cancer2002，38，： | 1 |
| 9 | Down-regulates bel-2 expression and potentiates apoptosis induction by bcl-2/bcl-XL bispeeifle antisense oligonueleotides in HER-2 gene-amplified breast cancer cells显示文摘 | Milella Trisciuoglio D Bruno T | 2004 | Clinical Cancer Research2004，10，7： | 1 |
| 10 | Bcl -2 has differing effects on the sensitivity of breast cancer cells depending on the antineoplasfic drug used 显示文摘 | Del Bufalo D Biroccio A Trisciuoglio D | 2002 | Eur J Cancer2002，38，18： | 1 |
| 11 | Bcl-2 overex pression in human melanoma cells increases angiogenesis through VEGF mRNA stabilization and HIF-1-mediated transcriptional activity显示文摘 | Iervolino A Trisciuoglio D Ribatti D | 2002 | FASEB J2002，16，11： | 1 |
| 12 | Differential involvement of vascular endothelial growth factor in the survival of hypoxic colon cancer cells显示文摘 | Calvani M Trisciuoglio D Bergamaschi C | 2008 | Cancer Res2008，68，1： | 1 |
| 13 | Induction of apoptosis in human cancer cells by candidaspongiolide,a novel sponge polyketide显示文摘 | Trisciuoglio D Uranchimeg B Cardellina J H | 2008 | J Natl Cancer Inst2008，100，12： | 1 |
| 14 | Involvement of BH4 domain of bcl-2 in the regulation of HIF-1 -mediated VEGF expression in hypoxic tumor cells显示文摘 | Trisciuoglio D Gabellini C | 2011 | Cell Death Differ2011，18，6： | 1 |
| 15 | Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression 显示文摘 | GABELLINI C TRISCIUOGLIO D DESIDERI M | 2009 | European Journal of Cancer2009，45，14： | 1 |
| 16 | Antiangiogenic potential of the mammalian target of rapamycin inhibitor temsirolimus 显示文摘 | Del Bufalo D Ciuffreda L Trisciuoglio D | 2006 | Cancer Res2006，66，： | 1 |
| 17 | Trastuzumab down regulates Bcl-2 expression and potentiates apoptosis indutian by Bcl-2/ BcI-XL bispecific antisense oligonucleotides in HER-2 gene-amplified breast cancer cells 显示文摘 | Milella M Trisciuoglio D Bruno T | 2004 | Clin Cancer Res2004，10，22： | 1 |
| 18 | Bcl-2 has differing effects on the sensitivity of breast cancer cells depending on the antineoplastic drug used显示文摘 | Del Bufalo D Biroccio A Trisciuoglio D | 2002 | Eur J Cancer2002，38，18： | 1 |
| 19 | Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on hu- man malignant melanoma progression 显示文摘 | Gabellini C Trisciuoglio D Desideri M | 2009 | Eur J Cancer2009，45，： | 1 |
| 20 | Involvement of hTERT in apoptosis induced by interference with Bcl-2 expression and function 显示文摘 | Del Bufalo D Rizzo A Trisciuoglio D | 2005 | Cell Death Differ2005，12，11： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员